Triamcinolone for diabetic retinopathy

نویسندگان

چکیده

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Triamcinolone and Bevacizumab as Adjunctive Therapies to Panretinal Photocoagulation for Proliferative Diabetic Retinopathy

Purpose. To evaluate efficacy of intravitreal triamcinolone (IVT) and bevacizumab (IVB) as adjunctive treatments to panretinal photocoagulation (PRP) in proliferative diabetic retinopathy (PDR). Methods. In 60 eyes of 45 patients with PDR, PRP (PRP group), PRP with IVT (IVT group), or PRP with IVB (IVB group) was performed. Regression of new vessels (NV), changes in best-corrected visual acuity...

متن کامل

Triamcinolone as adjunctive treatment to laser panretinal photocoagulation for proliferative diabetic retinopathy.

OBJECTIVE To evaluate intravitreal injection of triamcinolone acetonide before laser panretinal photocoagulation (PRP) in the treatment of proliferative diabetic retinopathy. METHODS This interventional case series included 9 patients with bilateral proliferative diabetic retinopathy. One eye received intravitreal triamcinolone before PRP (injected eye) and the other, PRP alone (control eye)....

متن کامل

Diabetic Retinopathy AMERICAN DIABETES ASSOCIATION SCREENING FOR DIABETIC RETINOPATHY

SCREENING FOR DIABETIC RETINOPATHY — Diabetic retinopathy is a highly specific vascular complication of both type 1 and type 2 diabetes. The prevalence of retinopathy is strongly related to the duration of diabetes. After 20 years of diabetes, nearly all patients with type 1 diabetes and 60% of patients with type 2 diabetes have some degree of retinopathy. Diabetic retinopathy poses a serious t...

متن کامل

Screening for Diabetic Retinopathy

D iabetic retinopathy is a highly specific vascular complication of both insulin-dependent (type I) and non-insulin-dependent (type II) diabetes mellitus. The prevalence of retinopathy is strongly related to the duration of diabetes. After 20 yr of diabetes, nearly all patients with type I diabetes and >60% of patients with type II diabetes have some degree of retinopathy. Diabetic retinopathy ...

متن کامل

new treatments for diabetic retinopathy

diabetic retinopathy is the leading cause of blindness in the world. strict control of blood sugar, blood pressure, laser therapy, pharmacotherapy and vitrectomy are of among common diabetic retinopathy treatments. further studies to investigate the effect of protein kinase c inhibitors, angiotensin converting enzyme inhibitors, growth hormone and other proposed treatments for diabetic retinopa...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Revista Brasileira de Oftalmologia

سال: 2015

ISSN: 0034-7280

DOI: 10.5935/0034-7280.20150041